Abstract:In cells, transcription is tightly regulated on multiple layers. The condensation of the transcription machinery into distinct phases is hypothesised to spatio-temporally fine tune RNA polymerase II behaviour during two key stages, transcription initiation and the elongation of the nascent RNA transcripts. However, it has remained unclear whether these phases would mix when present at the same time or remain distinct chemical environments; either as multi-phase condensates or by forming entirely separate condensates. Here we combine particle-based multi-scale simulations and experiments in the model organism C. elegans to characterise the biophysical properties of RNA polymerase II condensates. Both simulations and the in vivo work describe a lower critical solution temperature (LCST) behaviour of RNA Polymerase II, with condensates dissolving at lower temperatures whereas higher temperatures promote condensate stability. Importantly this gradual change in temperature correlates with an incremental transcriptional response to temperature but is largely uncoupled from the classical stress response. The LCST behaviour of CTD also highlights that these condensates are physio-chemically distinct from heterochromatin condensates. Expanding the simulations we model how the degree of phosphorylation of the disordered C-terminal domain of RNA polymerase II (CTD), which is characteristic for each step of transcription, controls demixing of CTD and pCTD in line with phase separation experiments. We show that the two phases putatively underpinning the initiation of transcription and transcription elongation constitute distinct chemical environments and are in agreement with RNA polymerase II condensates observed in C. elegans embryos by super resolution microscopy. Our analysis reveals how depending on its post-translational modifications and its interaction partners a single protein can adopt multiple morphologies and how partially engulfed condensates promote the selective recruitment of additional factors to the different phases.

Transcription regulation by biomolecular condensates

Dysregulation of transcriptional condensates in human disease: mechanisms, biological functions, and open questions

Nonspecific Interactions in Transcription Regulation and Organization of Transcriptional Condensates

Nuclear Protein Condensates and Their Properties in Regulation of Gene Expression

RNA in formation and regulation of transcriptional condensates

Emerging insights into transcriptional condensates

Transcriptional condensates: a blessing or a curse for gene regulation?

Transcriptional condensates and phase separation: condensing information across scales and mechanisms

Reconciling competing models on the roles of condensates and soluble complexes in transcription factor function

RNA-Mediated Feedback Control of Transcriptional Condensates

Mediator and RNA polymerase II clusters associate in transcription-dependent condensates

Mesoscale structure–function relationships in mitochondrial transcriptional condensates

Promoter and Gene-Body RNA-Polymerase II co-exist in partial demixed condensates

Condensation and activator/repressor control of a transcription-regulated biomolecular liquid

RNA and condensates: Disease implications and therapeutic opportunities

Targeted perturbation of signaling-driven condensates

Engineering Material Properties of Transcription Factor Condensates to Control Gene Expression in Mammalian Cells and Mice

Splicing regulation through biomolecular condensates and membraneless organelles

Biomolecular Condensates: Formation Mechanisms, Biological Functions, and Therapeutic Targets

Optogenetic control of mRNA condensation reveals an intimate link between condensate material properties and functions

Nucleated transcriptional condensates amplify gene expression